The primary aim of this study is to assess the feasibility of long-acting injectable naltrexone provided through primary care (LAN/PC) versus long-acting injectable naltrexone in the specialized chemical dependence clinic (LAN/CDC). The secondary aim is to obtain preliminary assessments of the relative effectiveness of long-acting injectable naltrexone in primary care versus in the chemical dependence clinic.
This study is currently recruiting patients.
Verified by State University of New York - Upstate Medical University March 2007
|Sponsors and Collaborators:||State University of New York - Upstate Medical University|
|Information provided by:||State University of New York - Upstate Medical University|